{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:38:50Z","timestamp":1761824330091},"reference-count":20,"publisher":"Japan Neurosurgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.2176\/nmccrj.cr.2020-0234","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T22:09:36Z","timestamp":1623449376000},"page":"253-259","source":"Crossref","is-referenced-by-count":5,"title":["Primary Central Nervous System T-cell Lymphoma as Methotrexate-associated Lymphoproliferative Disorders: Case Report"],"prefix":"10.2176","volume":"8","author":[{"given":"Hiroto","family":"KAWANO","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Japanese Red Cross Nagahama Hospital, Nagahama, Shiga, Japan"},{"name":"Department of Neurosurgery, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"KITAMURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"HIGUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Japanese Red Cross Nagahama Hospital, Nagahama, Shiga, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"NOZAKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","unstructured":"1) Ellman MH, Hurwitz H, Thomas C, Kozloff M: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. <i>J Rheumatol<\/i> 18: 1741\u20131743, 1991"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hasserjian RP, Chen S, Perkins SL, et al.: Immunomodulator agent-related lymphoproliferative disorders. <i>Mod Pathol<\/i> 22: 1532\u20131540, 2009","DOI":"10.1038\/modpathol.2009.131"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Salloum E, Cooper DL, Howe G, et al.: Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. <i>J Clin Oncol<\/i> 14: 1943\u20131949, 1996","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ichikawa A, Arakawa F, Kiyasu J, et al.: Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. <i>Eur J Haematol<\/i> 91: 20\u201328, 2013","DOI":"10.1111\/ejh.12116"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Katsuyama T, Sada KE, Yan M, et al.: Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. <i>Mod Rheumatol<\/i> 27: 773\u2013777, 2017","DOI":"10.1080\/14397595.2016.1259714"},{"key":"6","unstructured":"6) Hoshida Y, Xu JX, Fujita S, et al.: Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. <i>J Rheumatol<\/i> 34: 322\u2013331, 2007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Satou A, Tabata T, Miyoshi H, et al.: Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. <i>Mod Pathol<\/i> 32: 1135\u20131146, 2019","DOI":"10.1038\/s41379-019-0264-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kleinschmidt-DeMasters BK, Damek DM, Lillehei KO, Dogan A, Giannini C: Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. <i>J Neuropathol Exp Neurol<\/i> 67: 1103\u20131111, 2008","DOI":"10.1097\/NEN.0b013e31818beaea"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Fukushima M, Katayama Y, Yokose N, et al.: Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment. <i>Br J Neurosurg<\/i> 27: 824\u2013826, 2013","DOI":"10.3109\/02688697.2013.798857"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Migita K, Miyashita T, Mijin T, et al.: Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis. <i>Mod Rheumatol<\/i> 23: 832\u2013836, 2013","DOI":"10.3109\/s10165-012-0717-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Liu W, Xue J, Yu S, Chen Q, Li X, Yu R: Primary central nervous system lymphoma mimicking recurrent depressive disorder: a case report. <i>Oncol Lett<\/i> 9: 1819\u20131821, 2015","DOI":"10.3892\/ol.2015.2963"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shimada H, Dobashi H, Morimoto H, et al.: Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report. <i>BMC Res Notes<\/i> 88: 1\u20137, 2015","DOI":"10.1186\/s13104-015-1040-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kikuchi J, Kaneko Y, Kasahara H, et al.: Methotrexate-associated intravascular large B-cell lymphoma in a patient with rheumatoid arthritis. <i>Intern Med<\/i> 55: 1661\u20131665, 2016","DOI":"10.2169\/internalmedicine.55.6943"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Uchida Y, Hokkoku K, Hatanaka Y, Kikuchi Y, Tashiro H, Sonoo M: Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis. <i>Rinsho Shinkeigaku<\/i> 58: 485\u2013491, 2018","DOI":"10.5692\/clinicalneurol.cn-001157"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Haldorsen IS, Espeland A, Larsson EM: Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. <i>AJNR Am J Neuroradiol<\/i> 32: 984\u2013992, 2011","DOI":"10.3174\/ajnr.A2171"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P: Open-ring imaging sign: highly specific for atypical brain demyelination. <i>Neurology<\/i> 54: 1427\u20131433, 2000","DOI":"10.1212\/WNL.54.7.1427"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Zhang D, Hu LB, Henning TD, et al.: MRI findings of primary CNS lymphoma in 26 immunocompetent patients. <i>Korean J Radiol<\/i> 11: 269\u2013277, 2010","DOI":"10.3348\/kjr.2010.11.3.269"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Menon MP, Nicolae A, Meeker H, et al.: Primary CNS T-cell lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis. <i>Am J Surg Pathol<\/i> 39: 1719\u20131729, 2015","DOI":"10.1097\/PAS.0000000000000503"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Jiang H, Gao H, Wang Q, Wang M, Wu B: Molecular mechanisms and clinical application of Iguratimod: a review. <i>Biomed Pharmacother<\/i> 122: 109704, 2020","DOI":"10.1016\/j.biopha.2019.109704"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tokuhira M, Tamaru JI, Kizaki M: Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. <i>J Clin Exp Hematop<\/i> 59: 72\u201392, 2019","DOI":"10.3960\/jslrt.19007"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/8\/1\/8_cr.2020-0234\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T03:39:38Z","timestamp":1623469178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/8\/1\/8_cr.2020-0234\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2176\/nmccrj.cr.2020-0234","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}